Dec 3 2007
Cenamps have announced that a Tyneside firm has joined forces with a leading Japanese electronics manufacturer to develop a new range of ground-breaking, hi-tech devices to provide "nearer the patient" diagnoses of a range of diseases.
With the help of UK Trade & Investment's "Passport to Export" programme, early-stage nano biotechnology firm Orla Protein Technologies Ltd (Orla) has signed an agreement with the Japan Radio Co. Ltd (JRC), in Tokyo, to develop the new devices that can be used by doctors and paramedics to allow earlier and more effective treatment for patients, without the need for complex equipment.
Simple to use, small, low-cost and portable the devices can provide instant test results for viruses, bacteria and protein markers. Test results will be stored electronically and can be capable of wireless transmission, opening significant opportunities in the multi-million dollar diagnostics market.
Dale Athey, Chief Executive at Orla, explained:"This is a very exciting development for Orla and we are honoured to have a partner such as JRC. Their expertise in mass manufacture and sensor technology, combined with Orla's novel bio surface technology provides a fantastic opportunity to create a leading position in the bio diagnostic market."
Jeff Sanders, one of UK Trade & Investments International Trade Advisers, said: "We have been working with Orla for the past five years and have helped them develop a comprehensive export plan, that helped maximise the support available through UK Trade & Investment, including its Passport to Export programme.
"This carefully planned approach to international trade has been vital element of the company's success and its great to see that their hard work is now paying dividends. The partnership with JRC is an important development and we will continue to offer all the support we can to ensure its on going success."